Search

Amanda C. Walke

Examiner (ID: 15144, Phone: (571)272-1337 , Office: P/1722 )

Most Active Art Unit
1722
Art Unit(s)
1722, 1737, 1752, 1795
Total Applications
2746
Issued Applications
2313
Pending Applications
137
Abandoned Applications
352

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20412535 [patent_doc_number] => 12495793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => Preservation of stem cells [patent_app_type] => utility [patent_app_number] => 17/425383 [patent_app_country] => US [patent_app_date] => 2020-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 0 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425383 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/425383
Preservation of stem cells Jan 22, 2020 Issued
Array ( [id] => 17505450 [patent_doc_number] => 20220098552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => METHOD FOR THE IN VITRO OR EX VIVO AMPLIFICATION OF HUMAN ADIPOSE TISSUE STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/421840 [patent_app_country] => US [patent_app_date] => 2020-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421840 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/421840
METHOD FOR THE IN VITRO OR EX VIVO AMPLIFICATION OF HUMAN ADIPOSE TISSUE STEM CELLS Jan 12, 2020 Pending
Array ( [id] => 17299999 [patent_doc_number] => 20210395838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => COMPOSITIONS AND METHODS RELATED TO REPORTER SYSTEMS AND LARGE ANIMAL MODELS FOR EVALUATING GENE EDITING TECHNOLOGY [patent_app_type] => utility [patent_app_number] => 17/421279 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13386 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421279 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/421279
COMPOSITIONS AND METHODS RELATED TO REPORTER SYSTEMS AND LARGE ANIMAL MODELS FOR EVALUATING GENE EDITING TECHNOLOGY Jan 9, 2020 Abandoned
Array ( [id] => 17503439 [patent_doc_number] => 20220096541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => METHODS TO TREAT MITOCHONDRIAL-ASSOCIATED DYSFUNCTIONS OR DISEASES [patent_app_type] => utility [patent_app_number] => 17/421909 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421909 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/421909
METHODS TO TREAT MITOCHONDRIAL-ASSOCIATED DYSFUNCTIONS OR DISEASES Jan 9, 2020 Pending
Array ( [id] => 17398242 [patent_doc_number] => 20220040332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA [patent_app_type] => utility [patent_app_number] => 17/414263 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22694 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414263 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/414263
GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA Dec 18, 2019 Abandoned
Array ( [id] => 18005299 [patent_doc_number] => 20220364065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => COMPOSITION FOR REMOVING PLURIPOTENT STEM CELLS AND METHOD OF REMOVING PLURIPOTENT STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/414511 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414511 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/414511
COMPOSITION FOR REMOVING PLURIPOTENT STEM CELLS AND METHOD OF REMOVING PLURIPOTENT STEM CELLS Dec 18, 2019 Abandoned
Array ( [id] => 17480718 [patent_doc_number] => 20220088222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES [patent_app_type] => utility [patent_app_number] => 17/414425 [patent_app_country] => US [patent_app_date] => 2019-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24573 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414425 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/414425
COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES Dec 17, 2019 Pending
Array ( [id] => 17334697 [patent_doc_number] => 20220001028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => AAV VIRAL VECTORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/309403 [patent_app_country] => US [patent_app_date] => 2019-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46657 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/309403
AAV VIRAL VECTORS AND USES THEREOF Nov 26, 2019 Pending
Array ( [id] => 17357123 [patent_doc_number] => 20220017919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME [patent_app_type] => utility [patent_app_number] => 17/295093 [patent_app_country] => US [patent_app_date] => 2019-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295093 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295093
RECOMBINANT VECTORS SUITABLE FOR THE TREATMENT OF IPEX SYNDROME Nov 18, 2019 Pending
Array ( [id] => 17297862 [patent_doc_number] => 20210393701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => REGENERATIVE ABSCOPAL EFFECTS [patent_app_type] => utility [patent_app_number] => 17/309207 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -82 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309207 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/309207
REGENERATIVE ABSCOPAL EFFECTS Nov 7, 2019 Pending
Array ( [id] => 17274744 [patent_doc_number] => 20210380942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES [patent_app_type] => utility [patent_app_number] => 17/288376 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -53 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288376 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/288376
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES Oct 23, 2019 Abandoned
Array ( [id] => 17274738 [patent_doc_number] => 20210380936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => An Implantable Construct, Methods of Manufacturing, and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/288140 [patent_app_country] => US [patent_app_date] => 2019-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288140 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/288140
An Implantable Construct, Methods of Manufacturing, and Uses Thereof Oct 22, 2019 Abandoned
Array ( [id] => 17342019 [patent_doc_number] => 20220008350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => PROCESS FOR ENGINEERING TARGETED NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 17/309030 [patent_app_country] => US [patent_app_date] => 2019-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9661 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309030 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/309030
PROCESS FOR ENGINEERING TARGETED NANOPARTICLES Oct 15, 2019 Pending
Array ( [id] => 17258843 [patent_doc_number] => 20210371828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => INDUCED PLURIPOTENT CELL COMPRISING A CONTROLLABLE TRANSGENE FOR CONDITIONAL IMMORTALIZATION [patent_app_type] => utility [patent_app_number] => 17/284428 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284428 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/284428
INDUCED PLURIPOTENT CELL COMPRISING A CONTROLLABLE TRANSGENE FOR CONDITIONAL IMMORTALIZATION Oct 10, 2019 Pending
Array ( [id] => 17314826 [patent_doc_number] => 20210403874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => Method for Producing Stem/Precursor Cells, By Using Low Molecular Weight Compound, From Cells Derived From Endodermal Tissue or Organ [patent_app_type] => utility [patent_app_number] => 17/285038 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285038 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/285038
Method for Producing Stem/Precursor Cells, By Using Low Molecular Weight Compound, From Cells Derived From Endodermal Tissue or Organ Oct 10, 2019 Pending
Array ( [id] => 17214857 [patent_doc_number] => 20210348194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => ENGINEERED NUCLEIC ACID CONSTRUCTS ENCODING AAV PRODUCTION PROTEINS [patent_app_type] => utility [patent_app_number] => 17/282878 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45869 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -136 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282878 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/282878
ENGINEERED NUCLEIC ACID CONSTRUCTS ENCODING AAV PRODUCTION PROTEINS Oct 3, 2019 Abandoned
Array ( [id] => 17198643 [patent_doc_number] => 20210338737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => TISSUE REPAIR BY ACTIVATED CELLS [patent_app_type] => utility [patent_app_number] => 17/273461 [patent_app_country] => US [patent_app_date] => 2019-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273461 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/273461
TISSUE REPAIR BY ACTIVATED CELLS Aug 28, 2019 Pending
Array ( [id] => 17428706 [patent_doc_number] => 20220056414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => METHOD FOR PRODUCING A VIRUS-FREE PLATELET LYSATE MATERIAL [patent_app_type] => utility [patent_app_number] => 17/279305 [patent_app_country] => US [patent_app_date] => 2019-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4442 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279305 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/279305
METHOD FOR PRODUCING A VIRUS-FREE PLATELET LYSATE MATERIAL Aug 22, 2019 Pending
Array ( [id] => 20453243 [patent_doc_number] => 12516295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Generation of pancreatic progenitor cells and beta cells from human pluripotent stem cells [patent_app_type] => utility [patent_app_number] => 17/269233 [patent_app_country] => US [patent_app_date] => 2019-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 4 [patent_no_of_words] => 3728 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269233 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/269233
Generation of pancreatic progenitor cells and beta cells from human pluripotent stem cells Aug 21, 2019 Issued
Array ( [id] => 16932740 [patent_doc_number] => 20210198629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => COMPOSITIONS AND METHODS FOR INCREASING BEIGING OF WHITE ADIPOSE TISSUE [patent_app_type] => utility [patent_app_number] => 17/269964 [patent_app_country] => US [patent_app_date] => 2019-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33552 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269964 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/269964
COMPOSITIONS AND METHODS FOR INCREASING BEIGING OF WHITE ADIPOSE TISSUE Aug 19, 2019 Abandoned
Menu